Zobrazeno 1 - 10
of 563
pro vyhledávání: '"lichenoid eruption"'
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundImmune checkpoint inhibitors (ICIs) have revolutionized cancer treatment, yet they can induce immune-related adverse events (irAEs), including cutaneous toxicities such as lichenoid eruptions. Pembrolizumab, a PD-1 inhibitor, is known for i
Externí odkaz:
https://doaj.org/article/4a39f5081cde4b0f8996d4c4185ecb6b
Publikováno v:
Alʹmanah Kliničeskoj Mediciny, Vol 51, Iss 7, Pp 417-425 (2023)
Tyrosine kinase inhibitor imatinib is a standard agent for treatment of gastrointestinal stromal tumors (GIST). Treatment courses are quite long and are usually well tolerated. However, skin rash can occur on treatment, with a prevalence of 7 to 88.9
Externí odkaz:
https://doaj.org/article/8d1b6558ba104520b66f3231de0e140c
Publikováno v:
Indian Dermatology Online Journal, Vol 15, Iss 3, Pp 492-495 (2023)
Imatinib and nilotinib are inhibitors of tyrosine kinases (TKIs) generated from the bcr-abl fusion protein, c-Kit, and platelet-derived growth factor receptors. Cutaneous adverse effects (AEs) of TKI are the most frequent non-hematological sequelae.
Externí odkaz:
https://doaj.org/article/059c56fe014444c190ee447cda29f7a3
Autor:
Risa Kakuta, Keiji Tanese, Kenro Hirata, Katsura Emoto, Sakiko Takeuchi, Chihiro Shiiya, Masayuki Amagai, Akiharu Kubo
Publikováno v:
JEADV Clinical Practice, Vol 2, Iss 3, Pp 594-597 (2023)
Abstract Recently, immune checkpoint inhibitors have been administered for several cancers and have shown great efficacy. However, they are associated with various immune‐related adverse events. Here, we report a case with severe lichenoid eruption
Externí odkaz:
https://doaj.org/article/b74789de0217460d98e2cff48d6ab2ec
Publikováno v:
Annals of Indian Academy of Neurology, Vol 26, Iss 3, Pp 275-277 (2023)
Lichenoid drug eruptions are a type of skin reaction that is caused by medication and mimics idiopathic lichen planus. Various medications have been known to cause lichenoid drug eruptions, such as antibiotics, anti-convulsants, anti-diabetics, anti-
Externí odkaz:
https://doaj.org/article/f3ab1de0f4d84743aa40c57cc66ea332
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Azadeh Majidian, Maryam Seyedmajidi, Hamid Abbaszadeh, Majid Sharbatdaran, Sina Jafari, Hemmat Gholinia
Publikováno v:
Caspian journal of dental research, Vol 9, Iss 2, Pp 26-34 (2020)
Introduction: Oral lichen planus (OLP) is an immunologically mediated mucocutaneous diseases. Langerhans cells (LCs) are antigen presenting cells resident within oral mucosa which, together with intraepithelial lymphocytes, play a role in mucosal def
Externí odkaz:
https://doaj.org/article/cc86269da2ed4128a4c8a2799c6393fe
Autor:
Manjyot Gautam, Parag Chaudhari, Shuchi Priya, Vasundhara Singh, Nitin Nadkarni, Sharmila Patil
Publikováno v:
Indian Journal of Paediatric Dermatology, Vol 21, Iss 4, Pp 294-300 (2020)
Background: Lichenoid eruptions are a diverse group of inflammatory dermatoses, characterized clinically by flat-topped papules which resemble lichen planus (LP) and histologically by a lichenoid tissue reaction. There are many lichenoid dermatoses,
Externí odkaz:
https://doaj.org/article/18369f7662754a2387ff4eb50131898f
Autor:
Yonatan K. Sapadin, Elazar Mermelstein, Robert G. Phelps, Christopher F. Basler, JoAnn M. Tufariello, Mark G. Lebwohl
Publikováno v:
Vaccines, Vol 11, Iss 2, p 438 (2023)
Lichen planus is a distinctive mucocutaneous disease with well-established clinical and histopathologic criteria. Lichenoid eruptions closely resemble lichen planus and may sometimes be indistinguishable from it. Systemic agents previously associated
Externí odkaz:
https://doaj.org/article/7cc3e09b6e974ed6928fa05782fb8457
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.